Company press releases

Displaying 101 - 108 of 108 results
Released Company Title Industry Topic
21 Oct 2021
07:00 CEST 		ARGENX SE argenx to Report Third Quarter 2021 Financial Results and Business Update on October 28, 2021 20103010 Biotechnology Other subject
08 Oct 2021
07:00 CEST 		ARGENX SE argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings 20103010 Biotechnology Other subject
03 Sep 2021
07:00 CEST 		ARGENX SE argenx to Present at Upcoming Investor Conferences 20103010 Biotechnology Other subject
25 Aug 2021
07:00 CEST 		ARGENX SE argenx Announces Validation of European Marketing Authorization Application for Efgartigimod in Generalized Myasthenia Gravis 20103010 Biotechnology Other subject
04 Aug 2021
07:00 CEST 		ARGENX SE argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference 20103010 Biotechnology Other subject
29 Jul 2021
07:00 CEST 		ARGENX SE argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Business Update 20103010 Biotechnology Other subject
22 Jul 2021
07:00 CEST 		ARGENX SE argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021 20103010 Biotechnology Other subject
14 Jul 2021
07:00 CEST 		ARGENX SE argenx to Host Virtual R&D Day on July 20, 2021 20103010 Biotechnology Other subject